Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Monotherapy	STARTED	Arm 1=High AR Nilutamide	14
Monotherapy	STARTED	Arm 2= Low AR Dasatinib	17
Monotherapy	COMPLETED	Arm 1=High AR Nilutamide	12
Monotherapy	COMPLETED	Arm 2= Low AR Dasatinib	11
Monotherapy	NOT COMPLETED	Arm 1=High AR Nilutamide	2
Monotherapy	NOT COMPLETED	Arm 2= Low AR Dasatinib	6
Combination Nilutamide and Dasatinib	STARTED	Arm 1=High AR Nilutamide	12
Combination Nilutamide and Dasatinib	STARTED	Arm 2= Low AR Dasatinib	11
Combination Nilutamide and Dasatinib	COMPLETED	Arm 1=High AR Nilutamide	6
Combination Nilutamide and Dasatinib	COMPLETED	Arm 2= Low AR Dasatinib	3
Combination Nilutamide and Dasatinib	NOT COMPLETED	Arm 1=High AR Nilutamide	6
Combination Nilutamide and Dasatinib	NOT COMPLETED	Arm 2= Low AR Dasatinib	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00918385/flow